Unknown

Dataset Information

0

Deficiency of programmed cell death 4 results in increased IL-10 expression by macrophages and thereby attenuates atherosclerosis in hyperlipidemic mice.


ABSTRACT: Programmed cell death 4 (Pdcd4) is a newly defined inhibitor of transcription and translation and a tumor suppressor. Recent studies have suggested that Pdcd4 may also be involved in some inflammatory diseases. However, its role in atherosclerosis, a chronic inflammation of the arterial wall, remains to be investigated. Here, we found that Pdcd4 deficiency in mice increased the expression of IL-10 in macrophages and decreased the expression of IL-17 in T cells in the presence of an atherosclerosis-associated stimulator in vitro and in high fat-induced atherosclerotic plaques. Importantly, knocking out Pdcd4 led to a decrease in atherosclerotic lesions in Apoe(-/-) mice fed a high fat diet. This effect could be partly reversed by blocking IL-10 with a neutralizing antibody but not by the application of exogenous IL-17. Further mechanistic studies revealed that Pdcd4 negatively regulated the expression of IL-10 in an ERK1/2- and p38-dependent manner. These results demonstrate that Pdcd4 deficiency attenuates atherosclerosis in hyperlipidemic mice in part through the upregulation of the anti-inflammatory cytokine IL-10. This indicates that endogenous Pdcd4 promotes atherosclerosis and therefore represents a potential therapeutic target for patients with atherosclerosis.

SUBMITTER: Jiang Y 

PROVIDER: S-EPMC4947820 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Deficiency of programmed cell death 4 results in increased IL-10 expression by macrophages and thereby attenuates atherosclerosis in hyperlipidemic mice.

Jiang Yang Y   Gao Qi Q   Wang Liyang L   Guo Chun C   Zhu Faliang F   Wang Bo B   Wang Qun Q   Gao Fei F   Chen Youhai Y   Zhang Lining L  

Cellular & molecular immunology 20150713 4


Programmed cell death 4 (Pdcd4) is a newly defined inhibitor of transcription and translation and a tumor suppressor. Recent studies have suggested that Pdcd4 may also be involved in some inflammatory diseases. However, its role in atherosclerosis, a chronic inflammation of the arterial wall, remains to be investigated. Here, we found that Pdcd4 deficiency in mice increased the expression of IL-10 in macrophages and decreased the expression of IL-17 in T cells in the presence of an atheroscleros  ...[more]

Similar Datasets

| S-EPMC6829073 | biostudies-literature
| S-EPMC10067757 | biostudies-literature
| S-EPMC3338496 | biostudies-literature
| S-EPMC5486994 | biostudies-literature
| S-EPMC8182060 | biostudies-literature
| S-EPMC6242955 | biostudies-literature
| S-EPMC6334258 | biostudies-literature
| S-EPMC6495174 | biostudies-literature
| S-EPMC4314230 | biostudies-literature
| S-EPMC3664520 | biostudies-literature